High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.
Ricard NavinésGiovanni OrioloIgor HorrilloMyriam CaveroBruno AouizerateMartin SchaeferLucile CapuronJosé Javier MeanaRocío Martín-SantosPublished in: The international journal of neuropsychopharmacology (2022)
Serum S100B levels appear to be a useful biomarker of antidepressant response in MDD even when considering inflammatory and metabolic markers.